Accountability as a Competitive Advantage

Walk down any commercial corridor in a major US city, and you are likely to encounter several medspas and aesthetic practices operating within a few blocks of one another. From the sidewalk, they can appear virtually interchangeable, with the same neutral color palettes, Instagram-ready waiting rooms, and similar menus of injectables and energy-based treatments. To the observer, they may appear to be competitors of equal standing.

However, behind those similar storefronts, one business may be a fully compliant medical practice with a medical director, appropriately licensed and scoped providers, and a legally sound ownership structure. The other may be little more than an approximation of the same model: a medical director in name only, undertrained or improperly licensed injectors, gray-market drugs and injectables, and an ownership structure that violates its state’s Corporate Practice of Medicine (CPOM) restrictions.

The aesthetic market is booming, commoditizing, and increasingly competing on price. In such a market, accountability is a strategic advantage, because the market is rewarding it, and the data are clearer than most owners realize.

Many operators view ethics and compliance as cost centers: unavoidable expenses that constrain growth and must be managed accordingly. That perspective fundamentally mischaracterizes the underlying economics.

Accountability—to the law, to the practice of medicine, and to the patient in the chair—is a highly profitable and defensible growth strategy. The case for it is operational, not abstract. Accountability plays out across 4 pillars that directly influence revenue and profitability: hiring, medical supervision, product selection, and business ownership.

DIFFERENT MEDSPAS, 
DIFFERENT OUTCOMES

Consider the example of 2 well-established practices of similar size and market position, based on real medspas operating in different states.

The noncompliant practice has been in business for 15 years and is owned by a nonphysician. It generates roughly $100,000 in monthly revenue; allocates 20% of revenue ($20,000 each month) to advertising; and operates at a 20% profit margin. To maintain its current level of business, it must acquire approximately 100 new patients every month.

By comparison, the compliant practice has been operating for 10 years and is physician-owned and physician-run. It generates about $350,000 in monthly revenue; spends only 1.3% of revenue ($4500) on advertising; and operates at a 35% profit margin. To maintain its current level of business, it requires only 10 new patients a month.

Both practices operate in the same category, offer the same procedures, and have access to the same paid marketing channels. The fundamental difference is in the underlying business model. The compliant practice retains patients, generates organic referrals, and can charge a premium for its services. The noncompliant practice, by contrast, remains heavily dependent on paid acquisition and must continually advertise to sustain growth.

PILLAR 1: QUALIFIED STAFFING 
AND SCOPE

The first pillar—and perhaps the most fundamental and frequently violated—is scope of practice. Every state defines who can perform which procedures, yet the gap between what is legal and what actually occurs in medspas is wide.

When medspas rely on underqualified staff or direct licensed professionals to perform procedures outside their scope, the consequences can be substantial: complications, corrective treatments, dissatisfied patients, and 1-star reviews. These costs rarely appear as a distinct line item on a profit-and-loss statement, but they directly erode margins. In addition, operating outside the permitted scope of practice can expose the business and its owners to legal and sometimes criminal liability. In many cases, noncompliant medspas were started by someone who is unlicensed or who holds a license but does not have the legal authority to practice medicine. The individual may not even realize they are breaking the law, much less committing a felony.

The compliant model inverts the cost calculation. Qualified clinicians, supported by real training and continuing education, deliver consistent outcomes. They hire based on clinical acumen and a genuine drive to serve the patient’s best interests. When patients consistently achieve excellent outcomes and feel cared for by knowledgeable providers, they are far more likely to remain loyal to the practice over the long term. Consistent outcomes give providers a credible foundation for patient education. In turn, effective patient education is one of the strongest drivers of trust, patient retention, premium pricing, and referrals.

PILLAR 2: A REAL MEDICAL DIRECTOR, NOT “MAILBOX MONEY”

A real medical director has aesthetic-specific expertise, clinical presence in the practice, real supervisory responsibility for clinicians, written medical protocols, a defined response plan for complications and emergencies, and routine check-ins with the team. They are part of the practice, not just a name on a contract.

The noncompliant alternative is what the industry, with grim humor, refers to as “mailbox money”: a physician who effectively rents out their license to a medspa they rarely, if ever, visit. The practice has no meaningful clinical oversight, no established protocols, no hands-on supervision, and no qualified physician available to respond when a complication occurs.

A nurse or aesthetician operating under that arrangement may end up performing procedures beyond their legal scope of practice (ie, practicing medicine without a license). The provider, the absentee physician, and the entity itself may face liability in these circumstances. Recent cases have demonstrated just how severe the consequences can be, including a Texas medspa case in which a patient’s death led to multiple criminal charges, including a murder charge.¹ When medicine is practiced without real medical oversight, patients’ lives can be at stake.

A real medical director is also one of the most underused trust signals in aesthetics. Many patients specifically want to know that a physician is involved in their care. Naming, featuring, and making that physician genuinely accessible can strengthen patient trust, support premium pricing, sustain retention, and lower the cost of paid advertising, while greatly reducing risk.

PILLAR 3: AUTHENTIC PRODUCTS 
AND DEVICES

It is illegal to import any drug from a foreign country—including Canada or European countries—or to purchase prescription products from online sources, such as Alibaba or Amazon. The US Food and Drug Administration (FDA) and US Customs and Border Protection enforce both of these regulations, and enforcement actions have accelerated.

The clinical consequences have been well documented: patients have experienced rashes, infections, ineffective treatments after use of vials containing no active ingredient, and reactions when relabeled or misrepresented products are injected without certainty about their actual contents.

Recent enforcement actions have also uncovered counterfeit versions of neuromodulators and weight-loss drugs sourced from overseas marketplaces entering US practices.^2,3 These are not simply sourcing or compliance issues. When the chain of custody for an injectable product is compromised, the provider may not know what is actually being put into a patient’s body. In aesthetics, where injectable treatments are often performed in an outpatient setting, that can turn a cost-saving decision into a serious patient-safety event, with significant clinical, regulatory, financial, and reputational consequences.

PILLAR 4: COMPLIANT OWNERSHIP (CPOM DOCTRINE)

The fourth pillar is the one most owners misunderstand until a complaint forces the issue: ownership structure.

Almost every state has some version of the CPOM doctrine, and the bottom line is that, in many states, only a physician can own a medical practice, and corporations may be restricted from employing physicians directly. CPOM rules vary substantially by state; there is no template that works everywhere. Any decision about legal structure must be made with state-specific counsel and revisited any time the practice opens a location across state lines.

The standard solution is the Management Services Organization/Professional Corporation (MSO/PC) structure, in which a physician-owned PC owns the medical practice itself, while an MSO owns the spa-side assets—the lease, the equipment, the software, the brand—and provides management services to the practice. The medical practice PC collects payment for medical services and pays the MSO for managing the spa.

The importance of getting the structure right becomes clear when a complaint surfaces. Illegal ownership can turn what might otherwise be a routine matter into a disqualifying one.

A nonmedical owner or nurse cannot set up an MSO while paying a medical director to rent their license to make illegal ownership appear legitimate. In that case, the substance (what they are actually doing in practice) does not match the form (the legal documents). Courts and regulators can look beyond the legal paperwork to the actual arrangement. CPOM violations can carry criminal consequences.

THE COMPOUNDING EFFECT

The aforementioned pillars work together, with each one strengthening the others.

Qualified clinicians working with a real medical director produce better outcomes. Better outcomes achieved with authentic products produce referrals and 5-star reviews. Referrals and 5-star reviews reduce dependence on paid acquisition and support premium pricing. Compliant ownership keeps the entity durable enough to compound those advantages over years.

The financial result is predictable: lower customer acquisition costs, higher average order value, higher lifetime values, and higher margins. None of this requires a marketing innovation; it requires the practice to deliver on what it promises.

WHAT TO DO NEXT

A 5-question self-audit can provide important insight:

• Are all providers performing procedures within the scope of their licenses?
• Is the medical director clinically present in the practice, with appropriate protocols and a clear plan for managing complications?
• Can every vial in the refrigerator be traced back to a legitimate US manufacturer or authorized source?
• Does the ownership structure comply with the state’s CPOM rules?
• Could the practice withstand a regulatory complaint?

Practices that can answer yes to all 5 questions are increasingly distinguishable in the market—not only to patients but also to insurers, landlords, and regulators, who are actively enforcing these standards.

Third-party certification through organizations such as the Medspa Board can give compliant practices a credential to display and a defensible way to demonstrate their commitment to established standards—something bad actors cannot easily replicate. More practically, it gives patients something concrete to look for. In a market where consumers may struggle to distinguish among aesthetic practices, a verified standard matters.

The practices that have taken accountability seriously are increasingly being rewarded for it. Those that have not may be at risk of consequences.